Dodge & Cox Merck & Co., Inc. Transaction History

Dodge & Cox

$165 Billion
Q3 2024

A detailed history of Dodge & Cox transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dodge & Cox holds 158,251 shares of MRK stock, worth $15.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

158,251

Previous 158,876 0.39%

Holding current value

$15.5 Million

Previous $19.7 Million 8.63%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $69,468 - $80,606	-625 Reduced 0.39%	158,251 $18 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $200,432 - $215,262	-1,619 Reduced 1.01%	158,876 $19.7 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $50,958 - $59,377	-450 Reduced 0.28%	160,495 $21.2 Million
Q4 2023 Feb 15, 2024	SELL	$100.18 - $109.02 $285,513 - $310,707	-2,850 Reduced 1.74%	160,945 $17.5 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $684,617 - $760,294	-6,650 Reduced 3.9%	163,795 $16.9 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $299,872 - $326,847	-2,761 Reduced 1.59%	170,445 $19.7 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $208,453 - $232,591	-2,025 Reduced 1.16%	173,206 $18.4 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1.23 Million - $1.58 Million	-14,100 Reduced 7.45%	175,231 $19.4 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $295,855 - $332,360	-3,500 Reduced 1.82%	189,331 $16.3 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $601,128 - $681,408	-7,200 Reduced 3.6%	192,831 $17.6 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $1.04 Million - $1.16 Million	-14,127 Reduced 6.6%	200,031 $16.4 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $543,545 - $680,860	-7,520 Reduced 3.39%	214,158 $16.4 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $526,848 - $579,400	-7,350 Reduced 3.21%	221,678 $16.7 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $1.27 Million - $1.4 Million	-18,058 Reduced 7.31%	229,028 $17.8 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $1.93 Million - $2.28 Million	-28,078 Reduced 10.2%	247,086 $19 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $2.34 Million - $2.59 Million	-32,565 Reduced 10.58%	275,164 $22.5 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $2.8 Million - $3.17 Million	-38,250 Reduced 11.06%	307,729 $25.5 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $12 Million - $13.7 Million	-170,979 Reduced 33.07%	345,979 $26.8 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $10.9 Million - $15.1 Million	-172,438 Reduced 25.01%	516,958 $39.8 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $926,848 - $1.05 Million	-11,947 Reduced 1.7%	689,396 $62.7 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $1.01 Million - $1.1 Million	-13,279 Reduced 1.86%	701,343 $59 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $3.78 Million - $4.41 Million	-54,068 Reduced 7.03%	714,622 $59.9 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $4.27 Million - $4.87 Million	-61,335 Reduced 7.39%	768,690 $63.9 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $10.6 Million - $12.3 Million	-162,238 Reduced 16.35%	830,025 $63.4 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $133 Million - $157 Million	-2,312,846 Reduced 69.98%	992,263 $70.4 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $533 Million - $626 Million	-10,483,244 Reduced 76.03%	3,305,109 $201 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $284,509 - $330,681	-5,583 Reduced 0.04%	13,788,353 $751 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $17.1 Million - $20.4 Million	331,467 Added 2.46%	13,793,936 $776 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $790 Million - $850 Million	13,462,469	13,462,469 $862 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account